US 11,440,879 B2Granted

Methods of treating mood disorders

AssigneeGilgamesh Pharmaceuticals, Inc.

InventorAndrew Carry Kruegel

Life of this patent

Estimating the term…

Abstract

Methods of treating mood disorders with compounds disclosed herein. Also provided are pharmaceutical compositions that include those compounds.

Claims2

Dependent claims

A compound represented by:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 17/510,080Filed 25 Oct 2021 · continuation
Priority: 18 Feb 2020
Published: US 2022/0041551 A110 Feb 2022
Granted: 13 Sep 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 31/404
Condensed with carbocyclic rings, e.g. carbazole: indoles, e.g. pindolol
C07D 209/16
Radicals substituted by nitrogen atoms, not forming part of a nitro radical: tryptamines
A61K 31/4045
Indoles, e.g. pindolol: indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
A61P 25/18
Drugs for disorders of the nervous system: antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Family

Application62/978,075Us provisional application · filed 18 Feb 2020
PCT/US2021/018534Parent of this continuation-in-part · filed 18 Feb 2021
Application17/404,923Parent of this continuation · filed 17 Aug 2021
US 2022/0041551 A1Pre-grant publication · published 10 Feb 2022
Application17/404,923Parent of this continuation-in-part
US 2022/0241243 A1Published application
US 11,440,879 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results